Ironwood Pharmaceuticals, Inc.IRWDNASDAQ
Loading
Net Income ScalingExpanding
Percentile Rank79
3Y CAGR-48.4%
5Y CAGR-25.7%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
-48.4%/yr
Annual compound
5Y CAGR
-25.7%/yr
Recent deceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$24.02M+2629.2%
2024$880000.00+100.1%
2023$-1.00B-672.5%
2022$175.06M-66.9%
2021$528.45M+397.7%
2020$106.18M+393.7%
2019$21.50M+107.6%
2018$-282.37M-141.5%
2017$-116.94M-43.1%
2016$-81.71M-